Find information on thousands of medical conditions and prescription drugs.

Facioscapulohumeral muscular dystrophy

Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant form of muscular dystrophy that initially affects muscles of the face (facio), scapula (scapulo) and upper arms (humeral). It is the third most most common genetic disease of skeletal muscle. Symptoms may develop in early childhood and are usually noticeable in the teenage years with 95% of affected individuals manifesting disease by age 20 years. A progressive skeletal muscle weakness usually develops in other areas of the body as well; often the weakness is asymmetrical. Life expectancy is normal, but up to 15% of affected individuals become severely disabled and eventually must use a wheel chair. more...

Home
Diseases
A
B
C
D
E
F
Fabry's disease
Facioscapulohumeral...
Factor V Leiden mutation
Factor VIII deficiency
Fallot tetralogy
Familial adenomatous...
Familial Mediterranean fever
Familial periodic paralysis
Familial polyposis
Fanconi syndrome
Fanconi's anemia
Farber's disease
Fascioliasis
Fatal familial insomnia
Fatty liver
Febrile seizure
Fibrodysplasia ossificans...
Fibromatosis
Fibrosarcoma
Fibrosis
Fibrous dysplasia
Filariasis
Fissured tongue
Fitz-Hugh-Curtis syndrome
Flesh eating bacteria
Fluorosis
Focal dystonia
Foix-Alajouanine syndrome
Follicular lymphoma
Fountain syndrome
Fragile X syndrome
Fraser syndrome
FRAXA syndrome
Friedreich's ataxia
Frontotemporal dementia
Fructose intolerance
Fructose-1,6-bisphosphatase...
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Non-muscular symptoms frequently associated with FSHD include subclinical sensorineural hearing loss and retinal telangectasias. The pathophysiology of FSHD is not known. Muscle histologic changes are nonspecific for the muscle wasting. There is evidence of early inflammatory changes in the muscle, but reported responses to high dose open labeled corticosteroid treatment have been negative. Animal studies of anabolic effects of beta adrenergic agonists on models of muscle wasting led to an open trial of albuterol (a beta adrenergic agonist) in which limited preliminary results support an improvement of muscle mass and strength in FSHD. Preliminary studies of muscle cultures suggest an increased sensitivity to oxidative stress, but require further exploration.

More than 95% of cases of FSHD are associated with the deletion of integral copies of a tandemly repeated 3.3kb unit (D4Z4 repeat) at the subtelomeric region 4q35. Inheritance is autosomal dominant, though up to one-third of the cases appear to be the result of de novo (new) mutations. The deletion appears to result in global dislocation of gene expression. If the entire region is removed, there are birth defects, but no specific defects on skeletal muscle. Individuals appear to require the existence of 11 or fewer repeat units to be at risk for FSHD. Though the nature of the DNA mutation is known, it has not been possible to identify a gene or mechanism that causes FSHD and a novel position effect has been postulated to explain the disease phenotype. In addition, some cases of FSHD are the result of rearrangements between subtelomeric chromosome 4q and a subtelomeric region of 10q that contains a tandem repeat structure highly homologous (95%) to 4q35. Disease occurs when the translocation results in a critical loss of tandem repeats to the 4q site. Finally, there is a large family with a phenotype indistinguishable from FSHD in which no pathological changes at the 4q site or translocation of 4q-10q are found.

Read more at Wikipedia.org


[List your site here Free!]


Muscular Dystrophy
From Gale Encyclopedia of Childhood and Adolescence, 4/6/01 by Mary McNulty

The major types of muscular dystrophy (MD) are Duchenne, limb-girdle, facioscapulohumeral (FSH), Becker, and myotonic. In the United States, 250,000 people are affected by muscular dystrophy, with boys disproportionally represented at the rate of one in every 4,000 births.

Duchenne, the most severe form of muscular dystrophy, is passed exclusively by a defective gene in the mother to her son. A woman with the defective gene has a 50% chance of bearing a son with Duchenne muscular dystrophy. Female children of carrier mothers have a 50% chance of being carriers themselves. In this disease, the muscles of the lower body and spine are affected first; onset is in early childhood between the ages of two and six years. Nearly one-half of all Duchenne victims do not walk until after they reach 18 months old. When they do begin walking, it is usually with a waddling or swaying gait. The child will also have difficulty getting up from the floor or standing on one foot and may tire easily. A child with Duchenne MD has a tendency to walk on the toes, which causes the pelvis to tilt forward, resulting in lordosis, a hollowing of the back. The disease also creates muscle enlargement, especially in the calf. Dental problems, such as a widening of the jaw and spaces between the teeth, are also common. The child's arms are usually not affected until the latter stages of the disease.

Most victims of Duchenne MD lose the ability to walk between the ages of 10 and 13. This will result in bone deformities, scoliosis, and deterioration of the respiratory muscles. The child may also suffer from constipation due to constant sitting. Death usually results from respiratory infection or heart failure. Borderline mental retardation and slowed intellectual development occasionally accompany Duchenne MD. However, many patients have above-average intelligence .

Limb-girdle muscular dystrophy describes a group of diseases that affect the muscles in the pelvic area and manifests itself in late childhood to middle age. Its effects range from mild to debilitating. An early onset of limb-girdle muscular dystrophy usually signals a swift and severe case. It shares the toe walking and muscle enlargement features characteristic of Duchenne. However, the heart and mental development are usually not affected. Limb-girdle MD is passed on to boys when the defective gene is carried by both parents.

Facioscapulohumeral (FSH) muscular dystrophy is a mild form of the disease involving the muscles of the shoulders, upper back, and face. It appears in adolescence, affecting both boys and girls. FSH is inherited from a parent who also suffers from FSH. Victims' face muscles tend to weaken first; they cannot close their eyes tightly, purse their lips to blow, or puff out their cheeks. This is followed by a weakening of the shoulder and upper back muscles, making it difficult for the child to raise his arms, or to lift objects. The shoulder blades push upward towards the head, creating a "terracing" characteristic.

Becker muscular dystrophy is similar to Duchenne in that it is passed to sons from mothers possessing the defective gene. The symptoms are also similar to Duchenne and occur between two and 16 years of age. Victims of Becker MD generally walk until adulthood and live into their 30s and even 50s. Heart complications are rare.

Myotonic dystrophy, also known as Steinert's disease, attacks the eyes, heart, and testes. Its most telling characteristic is the inability of the muscles to relax after sudden, vigorous exertion.

Three laboratory tests are administered to determine the existence of muscular dystrophy. A blood test can pick up proteins leaked by the muscles even before muscle weakness occurs. An electromyogram will register certain tracings if muscles are diseased. A biopsy of muscle tissue can also detect the condition.

Because no cure exists for muscular dystrophy, the focus of parents and medical professionals is to help the patient maintain his mobility as long as possible and to remain an active member of society. The child should be encouraged to exercise the affected muscles, even during periods of illness. Parents should also work closely with teachers to provide a positive educational environment for the child. Time allowances should be made to accommodate the child's difficulty in turning textbook pages, grasping a pencil or pen, and traveling within the classroom and school buildings. Participation in physical education classes should be allowed as much as possible. Even if the child cannot play a particular game, he can keep score or be involved in other ways.

Muscular dystrophy is an extremely difficult challenge for a young person to face, and emotional support is of utmost importance. Summer camps operated by the Muscular Dystrophy Association have been very effective in building self esteem in MD patients. Parents and other family members may find encouragement in joining support groups.

Further Reading

For Your Information

Books

  • Corrick, James A. Muscular Dystrophy. New York: F. Watts, 1992.
  • Donsbach, Kurt W., and H. Rudolph Alsleben. Multiple Sclerosis, Muscular Dystrophy and ALS. USA: Rockland Corporation, 1993.

Gale Encyclopedia of Childhood & Adolescence. Gale Research, 1998.

Return to Facioscapulohumeral muscular dystrophy
Home Contact Resources Exchange Links ebay